UBS Group
LOACR

UBS Group’s Longevity Acquisition Corporation Right LOACR Stock Holding History

UBS Group’s Portfolio LOACR Stock Details LOACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,103
Closed -$1K – 9046
2020
Q3 		$1K Buy
4,103
+1,419
+53% +$325 ﹤0.01% 7905
2020
Q2 		$1K Buy
+2,684
New +$415 ﹤0.01% 7869

Other funds holding LOACR

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

UBS Group's LOACR Position: Q4 2020 in Review

UBS Group sold out of Longevity Acquisition Corporation Right (LOACR) in Q4 2020, closing a stake of 4,103 shares — an estimated $1K sold.

UBS Group first reported a position in LOACR in Q2 2020 and held it in 2 quarters. The position peaked at $1K in Q3 2020. 7 funds tracked by Wall St. Rank hold LOACR as of Q4 2020.

  • UBS Group reported no remaining Longevity Acquisition Corporation Right position as of Q4 2020 after selling out during the quarter.
  • UBS Group sold 4,103 Longevity Acquisition Corporation Right shares in Q4 2020, an estimated $1K.
  • UBS Group first reported a position in Longevity Acquisition Corporation Right in Q2 2020 and held it in 2 quarters.
  • UBS Group's Longevity Acquisition Corporation Right position peaked at $1K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Right as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.